Drug Information

Drug General Information
Drug ID
D05TMQ
Former ID
DAP001034
Drug Name
Aprobarbital
Synonyms
Allional; Allonal; Allylisopropylmalonylurea; Allylpropymal; Allypropymal; Allypropymalum; Alurate; Aprobarbita; Aprobarbitale; Aprobarbitalum; Aprobarbitone; Aprozal; Numal; Allylisopropylbarbituric acid; Alurate elixir verdum; Aprobarbitale [DCIT]; Isopropylallylbarbituric acid; Alurate (TN); Aprobarbital (INN); Aprobarbital [INN:DCF]; Aprobarbitalum [INN-Latin]; Isonal (swedish); 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylethyl)-5-(2-propenyl)-(9CI); 5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione;5-(1-methylethyl)-5-prop-2-en-1-ylpyrimidine-2,4,6(1H,3H,5H)-trione; 5-(propan-2-yl)-5-(prop-2-en-1-yl)pyrimidine-2,4,6(1H,3H,5H)-trione; 5-Allyl-5-isopropylbarbiturate; 5-Allyl-5-isopropylbarbituricacid; 5-Isopropyl-5-allylbarbituric acid; 5-allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione; 5-propan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione
Drug Type
Small molecular drug
Indication Insomnia; Anesthesia [ICD9: 307.41, 307.42, 327.0, 780.51, 780.52, 338; ICD10:F51.0, G47.0, R20.0] Approved [535467], [551871]
Therapeutic Class
Anticonvulsants
Structure
Download
2D MOL

3D MOL
Formula
C10H14N2O3
Canonical SMILES
CC(C)C1(C(=O)NC(=O)NC1=O)CC=C
InChI
1S/C10H14N2O3/c1-4-5-10(6(2)3)7(13)11-9(15)12-8(10)14/h4,6H,1,5H2,2-3H3,(H2,11,12,13,14,15)
InChIKey
UORJNBVJVRLXMQ-UHFFFAOYSA-N
CAS Number
CAS 77-02-1
PubChem Compound ID
6464
PubChem Substance ID
10028, 415128, 5727746, 7847763, 8147043, 8154124, 10535432, 15340876, 29225441, 46504558, 48415576, 49873703, 57323463, 60758450, 75869617, 103165909, 104312135, 107951976, 117366167, 118547783, 124597297, 129398631, 134224534, 134338298, 134971988, 137006561, 144238838, 160964642, 163227306, 164835924, 165745210, 179225509, 198986708, 226457430, 240314481, 241138165, 249554849, 250047775
ChEBI ID
ChEBI:2791
SuperDrug ATC ID
N05CA05
SuperDrug CAS ID
cas=000077021
Target and Pathway
Target(s) Glutamate receptor AMPA subtype Target Info Binder [535467]
References
Ref 535467Determination of zidovudine/lamivudine/nevirapine in human plasma using ion-pair HPLC. J Pharm Biomed Anal. 2002 Jun 1;28(5):903-8.
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
Ref 535467Determination of zidovudine/lamivudine/nevirapine in human plasma using ion-pair HPLC. J Pharm Biomed Anal. 2002 Jun 1;28(5):903-8.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.